Searched for
MSN LABORATORIES
Semaglutide API price plunges amid GLP-1 rushGlobal demand for weight-loss drugs Ozempic and Wegovy has caused semaglutide prices to drop significantly. Manufacturing has expanded rapi...- Novo to track generic surge as semaglutide goes off patentNovo Nordisk is preparing for a surge of generic semaglutide drugs in India. The company's India head stated they will monitor rivals' pric...
- Three-day pharma industry event from Nov 25 to host global pharma leaders, exhibitors, investorsIndia's pharmaceutical industry total market size is projected to reach $130 billion by 2030 and an impressive $450 billion by 2047, highli...
- Weight is over! Pharma companies race to make weight-loss drug semaglutideIndian drugmakers, including Dr. Reddy's and Zydus Lifesciences, are investing heavily in manufacturing capabilities to launch generic vers...
- Allchem Lifescience files IPO papers with Sebi; aims to raise Rs 190-cr via fresh issueDrug maker Allchem Lifescience has filed preliminary papers with markets regulator Sebi seeking its approval to raise funds through an init...
- Boehringer Ingelheim obtains interim injunction against four Indian drug cos from selling its diabetes drugBI said the injunctions restrain the domestic pharma companies from infringing the patent of Linagliptin by advertising, launching, making,...
- Panel to meet today to take up applications seeking nod for MolnupiravirThe firms whose applications that will be taken up are Dr Reddy's Laboratories which has filed for approval in a consortium with five other...
- MSN Labs launches patented diabetes pill Jardiance after DRL, heats up potential legal battleEarlier, ET reported that Dr Reddy's Labs has launched copies of Jardiance. It has a valid patent in India until 2025.
- Aurobindo Pharma, MSN Labs seek DGCI nod for Phase-III trials of Merck's molnupiravirIn a meeting held on October 4, both the companies said that they “they want to discontinue phase III trial in moderate Covid-19 patients a...
- Two Indian drugmakers seek to end trials of Merck's antiviral drug for moderate COVID-19The two Indian drugmakers, Aurobindo Pharma and MSN Laboratories plan to continue late-stage trails of the drug for those with mild COVID-1...
- MSN Labs enters into licence agreement with DRDE for COVID-19 drug 2-DGDeveloped by DRDO, 2-DG has been granted permission by the Drug Controller General of India (DCGI) for emergency use as adjunct therapy in ...
- Bajaj Healthcare moves Indian patent office for compulsory licence for Covid drugEli Lilly & Company declined the applications on both the occasion, citing the reason that it is really challenging for them to sign volunt...
- MSN Lab initiates Phase III clinical trial of Molnupiravir capsules for COVID-19 treatmentThe company said it has received its clinical trial approval on May 19, 2021, from the Drug Controller General of India (DCGI) to perform a...
- Eli Lilly inks pacts for COVID-19 drug Baricitinib with Torrent Pharma, Dr Reddy's, MSN LabsThe company has issued additional royalty-free, non-exclusive voluntary licences to Dr Reddy's, MSN Laboratories and Torrent Pharmaceutical...
- MSN Labs ties up with Eli Lilly for baricitinib in IndiaAs part of the COVID treatment range, MSN has already launched Favilow (Favipiravir) in the strengths of 200mg, 400mg and 800mg and Oselow ...
- Cipla arm secures marketing rights for cancer drug in USCipla USA, Inc, a subsidiary of the company will be marketing the drug in strengths of 150 and 500 mg tablets.
- Delhi HC turns down Bayer plea on stroke drug against Dr Reddy'sIn India, Bayer sells the product through its equal stake JV Bayer Zydus, formed with Ahmedabad-based Zydus Cadila.
- MSN Laboratories to foray into pain management market with launch of painkiller 'Tapentadol'MSN Laboratories Limited, will foray into the pain management market with the launch of 'Tapentadol' a pain killer under brand name Tapal i...
- Entrepreneurship bug bites pharma, biotech execsSenior professionals have earned enough expertise to start their own ventures at a time when the market and funding options are favourable.
- Pillion ride to etrepreneurshipProfessionals in pharma and biotechnology companies are increasingly taking the plunge to set up start-ups - a trend which investors descri...
Load More
